Overview
Flora Tech creates AI-powered tools and educational resources to support women’s health across menstruation, pregnancy, and sex education. The platform, guided by obstetricians and obstetric nurses, runs on a subscription model that gives users access to AI-driven apps and educational content. It targets students and working women, helping them manage physical and mental health and reduce societal biases around women’s health. The company builds an ecosystem by partnering with government agencies, medical researchers, and investors to expand its offerings. Its goal is to empower women with reliable knowledge and practical tools to maintain healthy lives.
Work here?Claim your company
Simplify's take
What believers are saying
- On April 27, 2026, Flora raised ¥230 million, lifting total funding near ¥500 million.
- Moonly surpassed 200,000 users, giving Flora proprietary women’s-health data for product learning.
- October 2026 wins with Ewel, Toyota Boshoku Kyushu, and Saikyo Bank expand distribution.
What critics are saying
- Flora remains tiny versus Flo Health and Apple, limiting brand power and data scale.
- Enterprise revenue depends on conservative Japanese HR budgets, delaying growth into 2027.
- If Wellflow stalls, Flora becomes a thin consultancy and loses fundraising credibility.
What makes FLORA unique
- Flora combines Moonly user data, Wellflow enterprise software, and Flora Expert insights.
- Its October 22, 2026 Ewel alliance broadens distribution through corporate benefits and health channels.
- Obstetric-guided products tie education, screening, and workplace support into one women’s-health stack.
Help us improve and share your feedback! Did you find this helpful?